Rhythm Pharmaceuticals Inc (RYTM)
37.35
-0.49
(-1.29%)
USD |
NASDAQ |
May 23, 16:00
37.35
0.00 (0.00%)
After-Hours: 17:19
Rhythm Pharmaceuticals 1 Year Total Returns (Daily): 121.7% for May 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 22, 2024 | 121.7% |
| May 21, 2024 | 126.7% |
| May 20, 2024 | 132.3% |
| May 17, 2024 | 130.5% |
| May 16, 2024 | 137.8% |
| May 15, 2024 | 134.5% |
| May 14, 2024 | 144.9% |
| May 13, 2024 | 143.8% |
| May 10, 2024 | 124.6% |
| May 09, 2024 | 125.0% |
| May 08, 2024 | 133.5% |
| May 07, 2024 | 135.8% |
| May 06, 2024 | 162.9% |
| May 03, 2024 | 136.3% |
| May 02, 2024 | 118.7% |
| May 01, 2024 | 105.0% |
| April 30, 2024 | 97.12% |
| April 29, 2024 | 92.46% |
| April 26, 2024 | 81.85% |
| April 25, 2024 | 80.38% |
| April 24, 2024 | 95.71% |
| April 23, 2024 | 92.31% |
| April 22, 2024 | 87.55% |
| April 19, 2024 | 79.89% |
| April 18, 2024 | 82.52% |
| Date | Value |
|---|---|
| April 17, 2024 | 88.02% |
| April 16, 2024 | 98.56% |
| April 15, 2024 | 106.6% |
| April 12, 2024 | 120.7% |
| April 11, 2024 | 129.9% |
| April 10, 2024 | 127.2% |
| April 09, 2024 | 143.8% |
| April 08, 2024 | 133.7% |
| April 05, 2024 | 129.3% |
| April 04, 2024 | 123.1% |
| April 03, 2024 | 119.8% |
| April 02, 2024 | 124.5% |
| April 01, 2024 | 139.2% |
| March 28, 2024 | 151.9% |
| March 27, 2024 | 144.2% |
| March 26, 2024 | 133.9% |
| March 25, 2024 | 134.6% |
| March 22, 2024 | 140.2% |
| March 21, 2024 | 127.2% |
| March 20, 2024 | 124.2% |
| March 19, 2024 | 118.1% |
| March 18, 2024 | 126.3% |
| March 15, 2024 | 119.4% |
| March 14, 2024 | 114.0% |
| March 13, 2024 | 114.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.02%
Minimum
May 18 2022
461.8%
Maximum
Jun 13 2023
30.20%
Average
0.46%
Median
Jul 09 2020
1 Year Total Returns (Daily) Benchmarks
| Pfizer Inc | -19.30% |
| Amicus Therapeutics Inc | -17.63% |
| Insmed Inc | 18.96% |
| Altimmune Inc | 76.12% |
| Regeneron Pharmaceuticals Inc | 30.91% |